论文部分内容阅读
目的 探讨舌下含服和口服等剂量的米索前列醇用于足月妊娠引产的效果、安全性和可接受性。方法 选择有医学或产科指征的孕 3 7周以上宫颈不成熟的孕妇 10 0例 ,随机分为舌下含服组和口服组 ,分别给予米索前列醇 5 0 ug,每 4h重复一次 ,最大剂量为 2 5 0 ug。前次剖宫产列为排
Objective To investigate the efficacy, safety and acceptability of misoprostol at sublingual and oral doses for induction of term labor. Methods A total of 100 pregnant women with cervical precancers of more than 3 weeks and older who underwent medical or obstetric indications were randomly divided into sublingual group and oral group. The patients were given misoprostol 50 ug, repeated every 4 hours, The maximum dose is 250 ug. Cesarean section as a row last row